EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
-5.0%/yr
vs +46.6%/yr prior
5Y CAGR
+2.4%/yr
Recent deceleration
Acceleration
-51.6pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $51.70M | -1.5% |
| 2024 | $52.49M | +1.3% |
| 2023 | $51.79M | -14.1% |
| 2022 | $60.32M | +13.7% |
| 2021 | $53.08M | +15.3% |
| 2020 | $46.02M | -3.5% |
| 2019 | $47.71M | +265.4% |
| 2018 | $13.06M | +16.2% |
| 2017 | $11.23M | +24.7% |
| 2016 | $9.01M | - |